Biosafety standards for working with Crimean-Congo hemorrhagic fever virus
Yazar
Uyar, Yavuz
Zeller, Herve
Weber, Friedemann
Swanepoel, Robert
Neyts, Johan
Niedrig, Matthias
ÖZKUL, AYKUT
Papa, Anna
Weidmann, Manfred
Avsic-Zupanc, Tatjana
Bino, Silvia
Bouloy, Michelle
Burt, Felicity
Chinikar, Sadegh
Christova, Iva
Dedushaj, Isuf
Schmaljohn, Connie S.
Sall, Amadou A.
Paweska, Janusz
El-Sanousi, Ahmed
ELALDI, NAZİF
Hewson, Roger
Hufert, Frank T.
Humolli, Isme
van Vuren, Petrus Jansen
Tufan, Zeliha Kocak
Korukluoglu, Gulay
Lyssen, Pieter
Mirazimi, Ali
Üst veri
Tüm öğe kaydını gösterÖzet
In countries from which Crimean-Congo haemorrhagic fever (CCHF) is absent, the causative virus, CCHF virus (CCHFV), is classified as a hazard group 4 agent and handled in containment level (CL)-4. In contrast, most endemic countries out of necessity have had to perform diagnostic tests under biosafety level (BSL)-2 or -3 conditions. In particular, Turkey and several of the Balkan countries have safely processed more than 100 000 samples over many years in BSL-2 laboratories. It is therefore advocated that biosafety requirements for CCHF diagnostic procedures should be revised, to allow the tests required to be performed under enhanced BSL-2 conditions with appropriate biosafety laboratory equipment and personal protective equipment used according to standardized protocols in the countries affected. Downgrading of CCHFV research work from CL-4, BSL-4 to CL-3, BSL-3 should also be considered.
Koleksiyonlar
- Makale [92796]